Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178787 · ClinicalTrials.gov registry record
UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT02178787 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT02178787 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Cerebral autoregulation (CA) is a complex mechanism that serves the essential and vital purpose of controlling cerebral blood flow and metabolism. A stable and optimal brain blood flow is imperative for normal brain function. Diabetes Mellitus (DM ) is associated with microvascular disease that alters CA and also with autonomic failure that may lead to orthostatic hypotension (OH). These conditions may lead to decreased brain blood flow in upright position. This observational study will compare two technologies that evaluate brain blood flow during standing up and other maneuvers in people with and without type 2 diabetes. These technologies are transcranial Doppler and UTLight technology (CerOx). This study will determine the safety and feasibility of CerOx technology for continuous monitoring of cerebral blood flow.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02178787
The ClinicalTrials.gov registry entry for NCT02178787 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02178787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02178787 about?
NCT02178787 is a clinical study titled "UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation". Cerebral autoregulation (CA) is a complex mechanism that serves the essential and vital purpose of controlling cerebral blood flow and metabolism. A stable and optimal brain blood flow is imperative for normal brain function. Diabetes Mellitus (DM ) is associated with microvascular disease that alte...
What is the current status of trial NCT02178787?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-04. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02178787?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.